Vitality Watch

Dossier clinicaltrials trial early 21-jul-2026
Small or early-phase human trial or pilot study

Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans

Key claim: Investigators propose that nicotinamide riboside supplementation will improve functional capacity and muscle physiology in older veterans by countering age-related NAD+ decline.

Abstract

Frailty is an age-associated clinical condition of poor physiological reserve that increases risks for falls, hospitalization and mortality. Nicotinamide adenine dinucleotide (NAD) is a critical co-factor needed for many cellular processes. The natural levels of NAD decline aging and this has been linked to physical performance decline in animals. Human trials have demonstrated that nicotinamide riboside (NR), a form of vitamin B3, is safe and effectively increases NAD+ levels. In animal studies, NR improves treadmill performance and muscle quality. Here the investigators propose a double-blind randomized control trial to assess the benefits of NR supplementation on human muscle function and physiology. The investigators anticipate the research findings will support the use of this nutritional supplement to improve the health of Veterans during aging.

Why this matters

Investigators propose that nicotinamide riboside supplementation will improve functional capacity and muscle physiology in older veterans by countering age-related NAD+ decline.

Source

Link

Briefing card

Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans
Stage: trial early · clinicaltrials · 21-jul-2026

Investigators propose that nicotinamide riboside supplementation will improve functional capacity and muscle physiology in older veterans by countering age-related NAD+ decline.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT04691986

build build 880 · 2bcef25 · 2026-11-18